- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 146 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- April 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 189 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 112 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- July 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP

The Plasmid market is a subset of the biotechnology industry that focuses on the production and sale of plasmids. Plasmids are circular pieces of DNA that can be used to transfer genetic material between cells. They are used in a variety of biotechnological applications, such as gene therapy, gene editing, and vaccine production. Plasmids are also used in research and development, as well as in the production of biopharmaceuticals.
The Plasmid market is highly competitive, with a number of companies offering a variety of products and services. Companies in the market include Thermo Fisher Scientific, Promega Corporation, GenScript, OriGene Technologies, and Addgene. These companies provide a range of products and services, including plasmid DNA, cloning services, and custom plasmid production. They also offer a variety of other services, such as gene synthesis, gene editing, and gene expression analysis. Show Less Read more